Physicians' Academy
for Cardiovascular Education
Agenda
Topics
▼
Video
▼
Online-CME
News
▼
Meeting Reports
Slides
▼
About
ACC.19
▼
AHA 2019
▼
Diabetes & CVD
▼
EAS 2019
▼
ESC 2019
▼
ESC Diabetes guidelines 2019
▼
ESC/EAS Guidelines dyslipidaemias 2019
▼
HFpEF: The essentials to know
▼
LDL-c Expert Meeting
▼
LDL-c Key Lessons
▼
PCSK9
▼
Statin Landmark Trials Across the Spectrum of Risk
Slides (presentation) - Apr. 7, 2011
Statin Landmark Trials Across the Spectrum of Risk:
Primary CV Prevention (8 slides)
Download 4. Stroke and CV Risk in Asia. landmark trials (PPTX 387KB)
Preview slide presentation - click on pictures
CHD Risk in MRFIT Trial
ASCOT LLA Trial of Statin in Hypertensive Patients
ASCOT LLA Primary End Point
ASCOT LLA Secondary End Point
HPS
CARDS: Effect of Atorvastatin on the Primary End Point
CARDS: Component End Points
Share this page with your colleagues and friends:
Share this page with your colleagues and friends: